Safety and Tolerability of Aclidinium Administered Intravenously and Absolute Bioavailability of Inhaled Aclidinium in Healthy Male Participants.
Phase of Trial: Phase I
Latest Information Update: 31 May 2011
At a glance
- Drugs Aclidinium bromide; Aclidinium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Almirall S.A.; Forest
- 31 May 2011 Results published in the Journal of Clinical Pharmacology.
- 21 Oct 2010 New trial record
- 22 Sep 2010 Results were presented at the 20th Annual Congress of the European Respiratory Society